Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALBlack Box

Firocoxib

Firocoxib

Standard Dose
Always provide the Client Information Sheet with prescription. Carefully consider the potential benefits and risks of Firocoxib and other treatment options before deciding to use Firocoxib.
Max Dose
See full prescribing information
Primary Use
Firocoxib label published in DailyMed.
Summary

Indications and usage Firocoxib label published in DailyMed.

Standard dosing Always provide the Client Information Sheet with prescription.

Structured Monograph

Clinical summary

Indications and usage Firocoxib label published in DailyMed. Standard dosing Always provide the Client Information Sheet with prescription. Carefully consider the potential benefits and risks of Firocoxib and other treatment options before deciding to use Firocoxib. Use the lowest effective dose for the shortest duration consistent with individual response. The recommended dosage of Firocoxib for oral administration in dogs is 2.27 mg/lb (5.0 mg/kg) body weight once daily as needed for osteoarthritis and for 3 days as needed for postoperative pain and inflammation associated with soft-tissue and orthopedic surgery. The dogs can be treated with Firocoxib approximately two hours prior to surgery. The tablets are scored and dosage should be calculated in half tablet increments. Firocoxib chewable tablets can be administered with or without food. Dose forms and strengths 57 mg FIROCOXIB; 60 1 FIROCOXIB Contraindications Dogs with known hypersensitivity to firocoxib should not receive Firocoxib. Key warnings Not for use in humans. Keep this and all medications out of the reach of children. Consult a physician in case of accidental ingestion by humans. For oral use in dogs only. Use of this product at doses above the recommended 2.27 mg/lb (5.0 mg/kg) in puppies less than seven months of age has been associated with serious adverse reactions, including death (see Animal Safety). Due to tablet sizes and scoring, dogs weighing less than 12.5 lb (5.7 kg) cannot be accurately dosed. All dogs should undergo a thorough history and physical examination before the initiation of NSAID therapy. Appropriate laboratory testing to establish hematological and serum baseline data is recommended prior to and periodically during administration of any NSAID. Owners should be advised to observe for signs of potential drug toxicity (see Adverse Reactions and Animal Safety) and be given a Client Information Sheet about Firocoxib chewable tablets. To report suspected adverse drug events, for technical assistance or to obtain a copy of the Safety Data Sheet, contact Covetrus® North America at (855) 724-3461 or covetrus.com. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae Keep Firocoxib in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose.

Boxed Warning

Not for use in humans. Keep this and all medications out of the reach of children.

Monitoring

  • Not for use in humans. Keep this and all medications out of the reach of children.

Interaction Notes

  • No interaction notes stored yet.
Firocoxib (Firocoxib) | Drug Monograph | MedicHelpline